Increased exposure in the MENA region
As the largest gathering of healthcare and trade professionals in the Middle East & North Africa (MENA), Arab Health is a key date in the Penlon calendar and the ideal opportunity to meet with distributors, healthcare providers and new customers.
This year’s event, which took place from 29th January to 1st February, welcomed over 4,200 exhibiting companies and 103,000 attendees from more than 150 countries.
Penlon’s stand, located in Hall 4, showcased anaesthesia systems from their range, including the new Prima 465, the MRI compatible Prima 451 and the ultra-compact Prima 440. Also on display were the award-winning Sigma Deltavaporizer and examples from our laryngoscope, suction control and oxygen therapy ranges.
In addition, a Penlon anaesthesia system was yet again used in the ABHI’s (Association of British Healthcare Industries) highly successful ‘Surgical Simulation Programme’ and this year it was the turn of the Prima 465. Several simulations took place each day, with specialist surgeons demonstrating new and ground breaking techniques to the gathered crowds.
Once again, Arab Health was a successful event for Penlon and plans are already underway for attending next year.
Penlon is delighted to announce the appointment of Gavin Gao as CEO.
For 44 years Arab Health has showcased the latest innovations in healthcare and once again Penlon will be exhibiting in Hall 4.
Penlon’s Sigma Delta vaporizer has undergone independent tests that confirm its compatibility with Draeger Auto-Exclusion®* and GE Selectatec® anaesthesia systems.
Penlon will be exhibiting at Med-Tech Innovation Expo 2018 this week